I help US-based early-stage biotechs streamline their early drug discovery and preclinical R&D by connecting innovative pipelines with high-efficiency Chinese and global CROs.
With hands-on project management experience across the full target-to-hit and hit-to-lead continuum — including DNA-Encoded Library (DEL) screening, protein production & crystallography-enabled SBDD, fragment-based drug discovery (FBDD), virtual screening, and medicinal chemistry optimization — I ensure clients achieve significant cost savings while maintaining the highest technical and data quality standards from their CRO partners.
Having managed 100+ DEL screening quotations and project workflows at WuXi AppTec, I understand the internal pricing logic, SOW structures, and technical boundaries of major service providers.
I help clients navigate vendor selection (e.g., WuXi vs. HitGen vs. Viva), benchmarking costs, and refining screening protocols to avoid common pitfalls in protein preparation and data interpretation.
I provide real-time project oversight on the ground while being able to enter into US-protected legal agreements. This significantly reduces communication lag and compliance risks.
Former Project Manager at WuXi AppTec (China & Germany), with over 4 years managing complex early discovery outsourcing projects for global clients.
I am passionate about helping small, fast-moving teams move faster and spend smarter. Whether you need help selecting the optimal CRO for protein crystallography, DEL screening, or hit-to-lead chemistry — or simply want a reliable partner to oversee execution in China — let’s connect.
Book a free 15-minute consultation to discuss your pipeline and how I can help you save time and budget.
Contact Me TodayGuaranteed response within 24 hours